Files in This Item:
   
ThumbnailEMHJ_2001_7_4-5_787_790.pdf

View/Open

Title: Efficacy of albendazole in giardiasis
Authors: Baqai, R.
Zuberi, S.J.
Qureshi, H.
Ahmed, W.
Hafiz, S.
Issue Date: 2001
Language: English
Abstract: Albendazole and metronidazole were compared in 68 patients diagnosed positive for giardiasis. Albendazole 1200 mg, one dose was given to 24 patients, albendazole 400 mg twice a day for 3 days was given to 23 patients, and metronidazole 400 mg 3 times a day for 5 days to 21 patients. Response to therapy was monitored by clinical examination and analysis of fresh faecal samples on days 0, 3, 7 and 10. Response to the single dose of albendazole was 55%, to the divided dose of albendazole 70%, and to metronidazole 84%. The results show that albendazole, originally recommended for helminthic infection, can also be used in patients with mixed protozoal infection or for infections resistant to metronidazole
Description: 787-790
Keywords: Antiprotozoal Agents
Drug Resistance
Feces
Giardiasis
Metronidazole
Subject: Albendazole
URI: http://www.who.int/iris/handle/10665/119089
ISSN: 1020-3397
Other Identifiers: http://applications.emro.who.int/emhj/0704_5/EMHJ_2001_7_4-5_787_790.pdf
Appears in Collections:EMRO Journal Articles (EMHJ)



Items in WHO IRIS are protected by copyright, with all rights reserved, unless otherwise indicated.